LYEL filings
Corporate insider profile
David Shook Filing Activity
Latest reported as Chief Medical Officer of Lyell Immunopharma, Inc. (LYEL).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$24,989.28
- Latest transaction
- Jun 10, 2026
Affiliated corporations
Reported company relationships
Transaction history
